Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treosulfan-Based Preparative Regimen for Haploidentical Stem Cell Transplantation in Hematological Malignancies
NCT04195633Phase 2Recruiting
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jan 2021
- Primary completion
- Apr 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of treosulfan in acute leukemia, chronic myelogenous leukemia (CML), chronic myelomonocytic leukemia (CMML), myelodysplastic syndrome (MDS), lymphoma, sponsored by Fred Hutchinson Cancer Center. Started Jan 2021; status: recruiting.
02
Drugs
treosulfan
03
Conditions
acute leukemiachronic myelogenous leukemia (CML)chronic myelomonocytic leukemia (CMML)myelodysplastic syndrome (MDS)lymphoma
Beyond the preview
Go deeper on NCT04195633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04195633.